ORIGINAL RESEARCH article
Front. Cardiovasc. Med.
Sec. Cardiovascular Metabolism
Machine Learning Prediction and SHAP Interpretability Analysis of Heart Failure Risk in Patients with Hyperuricemia
Provisionally accepted- Affiliated Hospital of Guilin Medical University, Guilin, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Aims: Cardiovascular disorders, particularly heart failure (HF), are a critical global health challenge. Hyperuricemia, a key cardiovascular risk factor, significantly increases HF susceptibility. Existing HF risk prediction tools are often cumbersome, relying on extensive clinical parameters and tests, limiting their practical use. Therefore, there is an urgent need for a simple, interpretable model to assess HF risk in hyperuricemia patients. Methods and results: Using 2005–March 2020 NHANES data (85,750 participants), 1,603 adults (≥18 years) with confirmed hyperuricemia were included. Accessible multidimensional indicators were selected for routine clinical use. Multiple machine learning models (Random Forest, Logistic Regression, XGBoost, SVM, etc.) were applied, with performance evaluated via accuracy, sensitivity, F1-score, and ROC AUC, etc. SHAP values analyzed feature importance for the best model. The SVM model showed the best overall performance, with chronic kidney disease, coronary heart disease, hypertension, serum potassium, serum osmolality, and sedentary time emerging as the top predictors. These six indicators demonstrated strong predictive power for HF in hyperuricemia patients, highlighting their clinical relevance. Conclusion: Integration of these six readily available indicators provides a simple, interpretable tool for HF risk stratification in hyperuricemia patients. While further longitudinal and multicenter validation is needed, the model shows promise for early identification and targeted intervention in clinical practice.
Keywords: Hyperuricemia, Heart Failure, machine learning, Shap, NHANES
Received: 20 Aug 2025; Accepted: 13 Nov 2025.
Copyright: © 2025 Gan, Wang, Mo, Li, Lu and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jin-yi Li, 17834968@qq.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
